| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 9.242 | 43.162 | 90.783 | 76.516 | 26.492 | 34.511 |
| Total Income - EUR | - | - | - | - | 10.008 | 63.777 | 93.762 | 79.456 | 29.414 | 37.400 |
| Total Expenses - EUR | - | - | - | - | 22.506 | 61.039 | 84.858 | 74.988 | 24.959 | 32.621 |
| Gross Profit/Loss - EUR | - | - | - | - | -12.498 | 2.737 | 8.903 | 4.468 | 4.455 | 4.779 |
| Net Profit/Loss - EUR | - | - | - | - | -12.588 | 2.174 | 8.080 | 3.808 | 4.252 | 4.129 |
| Employees | - | - | - | - | 1 | 4 | 4 | 3 | 1 | 2 |
Check the financial reports for the company - Positum Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 35.893 | 43.612 | 37.508 | 41.574 | 35.093 | 29.212 |
| Current Assets | - | - | - | - | 10.997 | 1.921 | 6.565 | 850 | 424 | 692 |
| Inventories | - | - | - | - | 0 | 34 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 8.093 | 1.867 | 5.838 | 534 | 0 | 0 |
| Cash | - | - | - | - | 2.904 | 20 | 727 | 316 | 424 | 692 |
| Shareholders Funds | - | - | - | - | -12.546 | -10.134 | -1.829 | 1.973 | 6.219 | 10.313 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 27.831 | 29.734 | 30.184 | 20.840 | 12.651 | 5.925 |
| Income in Advance | - | - | - | - | 31.605 | 25.933 | 22.454 | 19.610 | 16.647 | 13.666 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Positum Medica S.r.l.